vs
Side-by-side financial comparison of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.
ASCENTAGE PHARMA GROUP INTERNATIONAL is the larger business by last-quarter revenue ($32.6M vs $31.5M, roughly 1.0× Community Healthcare Trust Inc).
Ascentage Pharma Group International is a global clinical-stage biotechnology company specializing in developing novel targeted therapies for cancers, chronic viral infections, and age-related diseases. It focuses on small molecule drugs targeting apoptosis pathways and other key oncogenic mechanisms, with operations spanning China, the U.S., and other global markets, serving patients with unmet medical needs worldwide.
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
AAPG vs CHCT — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $32.6M | $31.5M |
| Net Profit | $11.4M | $2.5M |
| Gross Margin | 90.7% | — |
| Operating Margin | — | — |
| Net Margin | — | 8.1% |
| Revenue YoY | — | 4.8% |
| Net Profit YoY | — | 60.2% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $31.5M | ||
| Q4 25 | — | $30.9M | ||
| Q3 25 | — | $31.1M | ||
| Q2 25 | $32.6M | $29.1M | ||
| Q1 25 | — | $30.1M | ||
| Q4 24 | — | $29.3M | ||
| Q3 24 | — | $29.6M | ||
| Q2 24 | — | $27.5M |
| Q1 26 | — | $2.5M | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | $11.4M | $-12.6M | ||
| Q1 25 | — | $1.6M | ||
| Q4 24 | — | $1.8M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $-10.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 90.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 8.1% | ||
| Q4 25 | — | 46.6% | ||
| Q3 25 | — | 5.3% | ||
| Q2 25 | — | -43.2% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | -37.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.52 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $-0.50 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.04 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $-0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $2.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $421.3M |
| Total Assets | — | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.6M | ||
| Q4 25 | — | $3.3M | ||
| Q3 25 | — | $3.4M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $734.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | $532.2M | ||
| Q3 25 | — | $530.1M | ||
| Q2 25 | — | $500.1M | ||
| Q1 25 | — | $496.0M | ||
| Q4 24 | — | $486.0M | ||
| Q3 24 | — | $473.7M | ||
| Q2 24 | — | $457.6M |
| Q1 26 | — | $421.3M | ||
| Q4 25 | — | $429.4M | ||
| Q3 25 | — | $426.8M | ||
| Q2 25 | — | $437.8M | ||
| Q1 25 | — | $461.3M | ||
| Q4 24 | — | $476.0M | ||
| Q3 24 | — | $477.2M | ||
| Q2 24 | — | $497.8M |
| Q1 26 | — | $1.0B | ||
| Q4 25 | — | $990.8M | ||
| Q3 25 | — | $987.3M | ||
| Q2 25 | — | $966.3M | ||
| Q1 25 | — | $985.1M | ||
| Q4 24 | — | $992.6M | ||
| Q3 24 | — | $981.8M | ||
| Q2 24 | — | $983.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.24× | ||
| Q3 25 | — | 1.24× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 0.99× | ||
| Q2 24 | — | 0.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAPG
| Products | $29.7M | 91% |
| Others | $2.9M | 9% |
CHCT
Segment breakdown not available.
